Dilution is modest (3.1%) and the deal is closed, removing execution risk. The AMPLIFIER cross-filing signals suggest the market may focus on the combined roll-up narrative (MagCanica + Omnetics) and Arcline's platform strategy. Monitor Q3 results for margin accretion and integration costs; avoid over-weighting this announcement given past negative drift on even high-score calls.
Price Chart
Executive Summary
Arxis completed its previously announced acquisition of Omnetics Connector Corporation for ~$770M enterprise value, financed with 13.35M shares (~3.1% dilution). The deal is combined with a prior MagCanica acquisition at ~12x FY27 estimated adjusted EBITDA, expanding Arxis' electronic components segment in defense/aerospace connectors.
Key Financial Metrics
Key Facts
- Enterprise value ~$770M for Omnetics Connector Corporation.
- Arxis issued 13,351,964 shares (~3.1% total common shares) as consideration, subject to lockup.
- Combined purchase price multiple with MagCanica: ~12x FY27 estimated adjusted EBITDA.
- Omnetics makes high-reliability micro/nano connectors for defense, space, aerospace, and medical.
- Transaction is completed (not pending).
- Arxis formed in partnership with Arcline Investment Management (over $30B AUM).
- 88% of analyst ratings are Buy or Strong Buy; market cap ~$23.9B.
- Cross-filing actuarial context shows AMPLIFIER signals for press-8k + press-activist / press-offering combos.
Financial Impact
~$770M enterprise value; ~3.1% dilution via 13.35M shares issued.
Risk Factors
- Integration risk: combining two recent deals (MagCanica, Omnetics) may pressure margins.
- Lockup expiry could bring share overhang if former Omnetics holders sell.
- Combined purchase price multiple of ~12x FY27 adjusted EBITDA may be seen as full valuation.
- Share-price linked consideration (recent appreciation) could indicate overpayment perception.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302854063 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | EFFECT | $51.72 | awaiting T+60 | — | $52.43 (+1.37%) |
Oct 15, 2026 11d ago | Press Release | $54.10 | awaiting T+60 | — | $52.43 (−3.09%) |
Oct 13, 2026 14d ago | S-1 | $49.91 | awaiting T+60 | — | $52.43 (+5.05%) |
Sep 21, 2026 5w ago | SC 13G | $51.21 | awaiting T+60 | — | $52.43 (+2.38%) |
Aug 18, 2026 10w ago | 8-K | $56.56 | awaiting T+60 | — | $52.43 (−7.30%) |
Aug 18, 2026 10w ago | Press Release | $56.56 | awaiting T+60 | — | $52.43 (−7.30%) |
Aug 15, 2026 10w ago | Institutional Cluster | $57.60 | awaiting T+60 | — | $52.43 (−8.98%) |
Jun 2, 2026 21w ago | 8-K | $42.84 $53.83 | ▲ +25.65% | ▲ +24.54% | $52.43 (+22.39%) |
May 28, 2026 21w ago | 8-K | $46.83 $53.26 | ▲ +13.73% | ▲ +12.00% | $52.43 (+11.96%) |
Apr 17, 2026 27w ago | 8-K | $37.65 $41.55 | ▲ +10.36% | ▲ +3.58% | $52.43 (+39.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers